These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 619903)

  • 1. Pharmacokinetics of liposome-encapsulated anti-tumor drugs. Studies with vinblastine, actinomycin D, cytosine arabinoside, and daunomycin.
    Juliano RL; Stamp D
    Biochem Pharmacol; 1978 Jan; 27(1):21-7. PubMed ID: 619903
    [No Abstract]   [Full Text] [Related]  

  • 2. Organ-selective action of an antitumor drug: pharmacologic studies of liposome-encapsulated beta-cytosine arabinoside administered via the respiratory system of the rat.
    McCullough HN; Juliano RL
    J Natl Cancer Inst; 1979 Sep; 63(3):727-31. PubMed ID: 288932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of liposomes for the enhancement of the cytotoxic effects of cytosine arabinoside.
    Mayhew E; Papahadjopoulos D; Rustum YM; Dave C
    Ann N Y Acad Sci; 1978; 308():371-86. PubMed ID: 279297
    [No Abstract]   [Full Text] [Related]  

  • 4. Liposome-cell interactions. A study of the interactions of liposomes containing entrapped anti-cancer drugs with the EMT6, S49 and AE1 (transport-deficient) cell lines.
    Allen TM; McAllister L; Mausolf S; Gyorffy E
    Biochim Biophys Acta; 1981 May; 643(2):346-62. PubMed ID: 7225387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled delivery of an antitumor drug: localized action of liposome encapsulated cytosine arabinoside administered via the respiratory system.
    Juliano RL; McCullough HN
    J Pharmacol Exp Ther; 1980 Aug; 214(2):381-7. PubMed ID: 7391983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of CPX-351 (cytarabine/daunorubicin HCl) liposome injection in the mouse.
    Bayne WF; Mayer LD; Swenson CE
    J Pharm Sci; 2009 Jul; 98(7):2540-8. PubMed ID: 19009594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vivo distribution of daunomycin, acetyl kidamycin, actinomycin D and chromomycin A3].
    Fujita H; Sawabe T; Hanawa Y; Kimura K
    Gan No Rinsho; 1971 Mar; 17(3):196-204. PubMed ID: 5102102
    [No Abstract]   [Full Text] [Related]  

  • 8. The accumulation by fibroblasts of liposomally encapsulated vinblastine.
    Layton D; de Meyere J; Collard MP; Trouet A
    Eur J Cancer (1965); 1979 Dec; 15(12):1475-83. PubMed ID: 535610
    [No Abstract]   [Full Text] [Related]  

  • 9. Potentiation of drug effect by Tween 80 in Chinese hamster cells resistant to actinomycin D and daunomycin.
    Riehm H; Biedler JL
    Cancer Res; 1972 Jun; 32(6):1195-200. PubMed ID: 5030820
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination chemotherapy with cytosine arabinoside and daunomycin in childhood acute leukemia].
    Tsukimoto I; Mimaya J; Toyosaka H; Nagao T; Hanawa Y
    Rinsho Ketsueki; 1973 May; 14(5):596-603. PubMed ID: 4738276
    [No Abstract]   [Full Text] [Related]  

  • 11. Nuclear binding as a determinant of tissue distribution of adriamycin, daunomycin, adriamycinol, daunorubicinol and actinomycin D.
    Terasaki T; Iga T; Sugiyama Y; Sawada Y; Hanano M
    J Pharmacobiodyn; 1984 May; 7(5):269-77. PubMed ID: 6470925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vesicle size on the clearance, distribution, and tumor uptake of temperature-sensitive liposomes.
    Magin RL; Hunter JM; Niesman MR; Bark GA
    Cancer Drug Deliv; 1986; 3(4):223-37. PubMed ID: 3567843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biophysical characterization of a liposomal formulation of cytarabine and daunorubicin.
    Dicko A; Kwak S; Frazier AA; Mayer LD; Liboiron BD
    Int J Pharm; 2010 May; 391(1-2):248-59. PubMed ID: 20156541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quadruple combination chemotherapy of acute leukemia using daunomycin, cytosine arabinoside, vincristine and prednisolone (author's transl)].
    Yamaguchi H; Okabe N; Inoue A; Ichimaru M
    Rinsho Ketsueki; 1975 Jun; 16(6):589-98. PubMed ID: 1172055
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemotherapy with cytosine arabinoside, daunomycin and vincristine in refractory leukemia of childhood (author's transl)].
    Akatsuka J; Ueda Y; Ohmi K; Shike S; Nishimura K
    Rinsho Ketsueki; 1975 Oct; 16(10):931-5. PubMed ID: 1239527
    [No Abstract]   [Full Text] [Related]  

  • 16. Tissue distribution of antitumor drugs associated with polyalkylcyanoacrylate nanoparticles.
    Couvreur P; Kante B; Lenaerts V; Scailteur V; Roland M; Speiser P
    J Pharm Sci; 1980 Feb; 69(2):199-202. PubMed ID: 7359324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of acute myeloid leukemia in adults with a combination of daunomycin and cytosine-arabinoside].
    Brincker H
    Ugeskr Laeger; 1972 Oct; 134(42):2195-200. PubMed ID: 4563112
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy.
    Tardi P; Johnstone S; Harasym N; Xie S; Harasym T; Zisman N; Harvie P; Bermudes D; Mayer L
    Leuk Res; 2009 Jan; 33(1):129-39. PubMed ID: 18676016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose cytosine arabinoside and daunomycin as primary therapy for adults with acute nonlymphoblastic leukemia: a pilot study.
    Forman SJ; Nademanee AP; O'Donnell MR; Fahey JL; Snyder DS; Farbstein MJ; Lazar GS; DuBois NJ; Blume KG
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):114-6. PubMed ID: 4012336
    [No Abstract]   [Full Text] [Related]  

  • 20. Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.
    Huwyler J; Yang J; Pardridge WM
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1541-6. PubMed ID: 9316870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.